Kanabo Group PLC
LSE:KNB

Watchlist Manager
Kanabo Group PLC Logo
Kanabo Group PLC
LSE:KNB
Watchlist
Price: 0.0022 GBX -99.02% Market Closed
Market Cap: £13.9k

Operating Margin

-333.9%
Current
Improving
by 181.3%
vs 3-y average of -515.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-333.9%
=
Operating Income
£-3.8m
/
Revenue
£1.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-333.9%
=
Operating Income
GBX-3.8m
/
Revenue
£1.1m

Peer Comparison

Country Company Market Cap Operating
Margin
UK
Kanabo Group PLC
LSE:KNB
1.4m GBP
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

Lower than 97% of companies in United Kingdom
Percentile
3nd
Based on 3 579 companies
3nd percentile
-333.9%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

Kanabo Group PLC
Glance View

Market Cap
13.9k GBX
Industry
Pharmaceuticals

Kanabo Group Plc engages in the acquisition of a target company and business in the energy and industrial sectors. The firm is principally focused on distribution of cannabis-derived products for medical patients, and non- tetrahydrocannabinol (THC) products for Cannabidiol (CBD) consumers. The company has developed a formula for sleep disorders (insomnia), three CBD formulations for Reload, Relax, and Repair, and the VapePod, which is a vaporization delivery system for cannabis extract. The firm's R&D lab is set up in the Weizmann Science Park. The firm's clinical and validation activities, including safety and efficiency tests, are conducted in Israel. The firm is selling its initial products in Europe. The company is also engaged in conducting research and development (R&D) to develop cannabis oil formulas, medical-grade vaporizers, and various non-smoking consumption solutions.

KNB Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-333.9%
=
Operating Income
£-3.8m
/
Revenue
£1.1m
What is Kanabo Group PLC's current Operating Margin?

The current Operating Margin for Kanabo Group PLC is -333.9%, which is above its 3-year median of -515.1%.

How has Operating Margin changed over time?

Over the last 3 years, Kanabo Group PLC’s Operating Margin has increased from -8 266.7% to -333.9%. During this period, it reached a low of -8 266.7% on May 30, 2021 and a high of -333.9% on Jul 30, 2024.

Back to Top